EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Travels with tau prions

Marc I Diamond iD

Cytoskeleton · 2024

DOI: 10.1002/cm.21806 ↗

At a glance

Journal article in Cytoskeleton, 2024. Written by Marc I Diamond. Institution: Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, …. Major MEDLINE topics: Prions, Tauopathies. Cited 4 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tau was originally identified as a microtubule associated protein, and subsequently recognized to constitute the fibrillar assemblies found in Alzheimer disease and related neurodegenerative tauopathies. Point mutations in the microtubule associated protein tau (MAPT) gene cause dominantly inherited tauopathies, and most predispose it to aggregate. This indicates tau aggregation underlies pathogenesis of tauopathies. Our work has suggested that tau functions as a prion, forming unique intracellular pathological assemblies that subsequently move to other cells, inducing further aggregation that underlies disease progression. Remarkably, in simple cells tau forms stably propagating aggregates of distinct conformation, termed strains. Each strain induces a unique and, in some cases, transmissible, neuropathological phenotype upon inoculation into a mouse model. After binding heparan sulfate proteoglycans on the plasma membrane, tau assemblies enter cells via macropinocytosis. From within a vesicle, if not trafficked to the endolysosomal system, tau subsequently enters the cytoplasm, where it becomes a template for its own replication, apparently after processing by valosin containing protein. The smallest seed unit is a stable monomer, which suggests that initial folding events in tau presage subsequent pathological aggregation. The study of tau prions has raised important questions about basic cell biological processes that underlie their replication and propagation, with implications for therapy of tauopathies.

Subjects

MeSH terms (MEDLINE)

PrionsTauopathiesMiceAnimalstau ProteinsCell MembraneCytoskeletonBrain

Author keywords

fluorescencepriontautauopathy

Substances

tau ProteinsPrions

Authors and institutions

  • Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID profiles: Marc I Diamond

Cite

APA

Diamond, M. I. (2024). Travels with tau prions. Cytoskeleton. https://doi.org/10.1002/cm.21806

Vancouver

Diamond MI. Travels with tau prions. Cytoskeleton. 2024. doi:10.1002/cm.21806

BibTeX
@article{Diamond2024,
  author = {Diamond, Marc I},
  title = {Travels with tau prions},
  journal = {Cytoskeleton},
  year = {2024},
  doi = {10.1002/cm.21806}
}
Start for free →